Infectious disease consultation for Staphylococcus aureus bacteremia improves patient management and outcomes

Infectious Diseases in Clinical Practice

Volumn 20, Issue 4, 2012, Pages 261-267

  Pragman, Alexa A ^a   Kuskowski, Michael A ^a,b   Abraham, James M ^a   Filice, Gregory A ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

bacteremia; referral and consultation; Staphylococcus aureus

Indexed keywords

ADULT; AGED; ARTICLE; CONSULTATION; DEVICE INFECTION; FEMALE; HUMAN; INFECTION; MALE; OUTCOME ASSESSMENT; RELAPSE; STAPHYLOCOCCAL BACTEREMIA;

EID: 84863827517     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e318255d67c     Document Type: Article

References (45)

1. Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167:834-839.
2. Kaech C, Elzi L, Sendi P, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12:345-352.
3. Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478-486.
4. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000-1008.
5. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82:333-339.
6. Fortun J, Navas E, Martinez-Beltran J, et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis. 2001;33:120-125.
7. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990;34:1227-1231.
8. Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007;44:190-196.
9. Gentry CA, Rodvold KA, Novak RM, et al. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy. 1997;17:990-997.
10. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheterYrelated infections. Clin Infect Dis. 2001;32:1249-1272.
11. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992;14:75-82.
12. Malanoski GJ, Samore MH, Pefanis A, et al. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995;155:1161-1166.
13. Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med. 1976;84:558-560.
14. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891-907.
15. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med. 1976;60:495-500.
16. Bayer AS, Tillman DB, Concepcion N, et al. Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias. West J Med. 1980;132:294-300.
17. Ehni WF, Reller LB. Short-course therapy for catheter-associated Staphylococcus aureus bacteremia. Arch Intern Med. 1989;149:533-536.
18. Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheterYassociated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695-703.
19. Fowler VG Jr, Kong LK, Corey GR, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis. 1999;179:1157-1161.
20. Hartstein AI, Mulligan ME, Morthland VH, et al. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol. 1992;30:670-674.
21. Marr KA, Sexton DJ, Conlon PJ, et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127:275-280.
22. Lahey T, Shah R, Gittzus J, et al. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore). 2009;88:263-267.
23. Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16:1783-1788.
24. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultationVa study of 521 patients in Germany. J Infect. 2009;59:232-239.
25. Honda H, Krauss MJ, Jones JC, et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631-637.
26. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
27. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-1444.
28. Buck JM, Como-Sabetti K, Harriman KH, et al. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis. 2005;11:1532-1538.
29. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066-2072.
30. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
31. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665.
32. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med. 1984;144:541-545.
33. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
34. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
35. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170-1174.
36. Petrak RM, Sexton DJ, Butera ML, et al. The value of an infectious diseases specialist. Clin Infect Dis. 2003;36:1013-1017.
37. Gomez J, Conde Cavero SJ, Hernandez Cardona JL, et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother. 1996;38:309-314.
38. Nathwani D, Davey P, France AJ, et al. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. QJM. 1996;89:789-797.
39. Fluckiger U, Zimmerli W, Sax H, et al. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis. 2000;19:493-500.
40. Byl B, Clevenbergh P, Jacobs F, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60-66; discussion 67-68.
41. Grace C, Alston WK, Ramundo M, et al. The complexity, relative value, and financial worth of curbside consultations in an academic infectious diseases unit. Clin Infect Dis. 2010;51:651-655.
42. Leblebicioglu H, Akbulut A, Ulusoy S, et al. Informal consultations in infectious diseases and clinical microbiology practice. Clin Microbiol Infect. 2003;9:724-726.
43. Manian FA, McKinsey DS. A prospective study of 2,092 ''curbside'' questions asked of two infectious disease consultants in private practice in the Midwest. Clin Infect Dis. 1996;22:303-307.
44. Myers JP. Curbside consultation in infectious diseases: a prospective study. J Infect Dis. 1984;150:797-802.
45. Jover-Diaz F, Cuadrado-Pastor JM, Matarranz-del Amo M. Curbside consultation: another healthcare activity of the infectious disease specialist. Enferm Infecc Microbiol Clin. 2010;28:355-357.